|EQA 2023 - Biological Markers of Preeclampsia (PREE)|
Expert Biologists - Scheme Coordinators:
Louis LACAILLE and Bernard POGGI
EQA performed since 2021
Number of participating laboratories in 2022: 30
1 - Scheme Overview
This external quality assessment scheme assesses the accuracy of the assay of 3 serum markers used in the screening and monitoring of preeclampsia: sFlt1 (Soluble fms-like tyrosine kinase-1), PAPP-A (Pregnancy-associated plasma protein A) and PlGF (Placental growth factor).
2 - Assessment Frequency
Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 7
3 - List of Analytes Assessed
4 - Description of the Control Samples
Human or animal origin control serums in lyophilized form (samples to be resuspended in 1 or 2 mL of distilled water).